CHCHD10
Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial
Also known as: C22orf16, CHC10_HUMAN, MIX17A, N27C7-4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WYQ3
- Gene
- CHCHD10
- Ensembl
- ENSG00000250479
- Chromosome
- 22
- Canonical length
- 142 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a mitochondrial protein that is enriched at cristae junctions in the intermembrane space. It may play a role in cristae morphology maintenance or oxidative phosphorylation. Mutations in this gene cause frontotemporal dementia and/or amyotrophic lateral sclerosis-2. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 7 and 19. [provided by RefSeq, Aug 2014]
Canonical amino-acid sequenceUniProt
142 residues, UniProt reviewed canonical sequence.
>Q8WYQ3|CHCHD10
1 MPRGSRSAAS RPASRPAAPS AHPPAHPPPS AAAPAPAPSG QPGLMAQMAT TAAGVAVGSA
61 VGHVMGSALT GAFSGGSSEP SQPAVQQAPT PAAPQPLQMG PCAYEIRQFL DCSTTQSDLS
121 LCEGFSEALK QCKYYHGLSS LPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHCHD10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 1,596 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 1,596 nTPM
- skeletal muscle: 1,223 nTPM
- liver: 770 nTPM
- tongue: 616 nTPM
- choroid plexus: 459 nTPM
- kidney: 435 nTPM
Single-cell type
- hepatocytes: 1,707 nCPM
- colonocytes: 1,429 nCPM
- enterocytes: 1,161 nCPM
- epididymal clear cells: 959 nCPM
- parietal cells: 916 nCPM
- enteric transient amplifying cells: 910 nCPM
Immune cell
- memory B-cell: 12 nTPM
- eosinophil: 11 nTPM
- naive B-cell: 11 nTPM
- intermediate monocyte: 9.1 nTPM
- non-classical monocyte: 8.2 nTPM
- plasmacytoid DC: 7.4 nTPM
Brain region
- choroid plexus: 328 nTPM
- cerebral cortex: 240 nTPM
- thalamus: 210 nTPM
- hypothalamus: 176 nTPM
- pons: 171 nTPM
- basal ganglia: 169 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CHCHD10.
Disease | AllUniProt
Conditions CHCHD10 is implicated in, by any mechanism.
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 (FTDALS2) MIM:615911
- Spinal muscular atrophy, Jokela type (SMAJ) MIM:615048
- Myopathy, isolated mitochondrial, autosomal dominant (IMMD) MIM:616209
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 281 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal dominant mitochondrial myopathy with exercise intolerance
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 2
- Lower motor neuron syndrome with late-adult onset
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.91
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.82
- DepMap mean gene effect
- -0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- inner mitochondrial membrane organization
- mitochondrial membrane organization
- mitochondrion organization
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CHCHD10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHCHD10 as an antibody target. Whether an autoantibody or antibody against CHCHD10 could matter depends on whether native CHCHD10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHCHD10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CHCHD10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...